The Lancet Haematology· Francesco Pegoraro, Francesco Peyronel, Matthias Papo, Jerome Razanamahery, Francesco Catamerò, Giulia Palazzini, Ilaria Fibbi, Emmanuel Ledoult, Tanguy Le Scornet, Mathilde de Menthon, Etienne Rivière, Achille Aouba, Fleur Cohen-Aubart, Zahir Amoura, Ahmed Idbaih, Xavier Solanich, Polyzois Makras, Vanderson Rocha, Ofer Shpilberg, Oshrat Hershkovitz-Rokah, David L Pottinger, Laura E M Eurelings, Jan A van Laar, Astrid G S van Halteren, Michael Girschikofsky, Matthew J Koster, Nehaal Ahmed, Dongni Yi, Kristian Bowles, Alessandro Tomelleri, Corrado Campochiaro, Kevin O’Brien, Juvianee Estrada-Veras, Pierre Hirsch, Elena Sieni, Gaurav Goyal, Omar Abdel-Wahab, Jean-François Emile, Matthew Collin, Lorenzo Dagna, Ronald S Go, Eli L Diamond, Augusto Vaglio, Julien Haroche·· 2026-10-16AI 评分43
Erdheim–Chester 病的表型、治疗与预后决定因素:一项国际回顾性队列研究
[Articles] Phenotype, treatment, and determinants of prognosis in Erdheim–Chester disease: an international, retrospective, cohort study
AI 导读
一项跨多个时期的大型国际回顾性队列研究显示,Erdheim–Chester 病患者死亡率仍较高。研究聚焦该病的表型、治疗及预后决定因素,研究团队认为应早期识别高危特征患者,并制定风险适配的随访与治疗策略。
来源:The Lancet Haematology · thelancet.com